From: Primary and secondary transcriptional effects in the developing human Down syndrome brain and heart
Gene name | Chromosome | p value | Cerebrum | Cerebellum | Astrocyte | Heart | ||||
---|---|---|---|---|---|---|---|---|---|---|
 |  |  | Microarray | qPCR | Microarray | qPCR | Microarray | qPCR | Microarray | qPCR |
Pituitary tumor-transforming 1 interacting protein (PTTG1IP) | 21 | 1.50E-07 | 1.52 | 3.85 ± 0.38 | 1.42 | 1.46 ± 0.62 | 1.65 | 2.42 ± 1.16 | 1.74 | 1.41 ± 0.16 |
ATP synthase, H+ transporting, mitochondrial F1 complex, O subunit (ATP5O) | 21 | 5.11E-07 | 1.69 | 1.52 ± 0.20 | 1.75 | 0.91 ± 0.16 | 1.34 | 1.48 ± 0.72 | 1.69 | 3.52 ± 1.22 |
ATP synthase, H+ transporting, mitochondrial F0 complex, subunit F6 (ATP5J) | 21 | 2.47E-06 | 1.84 | 1.25 ± 0.14 | 1.40 | 1.19 ± 0.12 | 1.51 | 1.73 ± 0.78 | 2.23 | 5.19 ± 1.60 |
Down syndrome critical region gene 3 (DSCR3) | 21 | 1.44E-05 | 1.82 | 2.76 ± 0.44 | 1.86 | 0.79 ± 0.38 | 3.40 | 2.50 ± 0.62 | 0.98 | 2.06 ± 0.06 |
Chromosome 21 segment HS21C048, zinc finger protein 294 (ZNF294) | 21 | 3.39E-05 | 1.71 | 2.58 ± 0.24 | 1.42 | 1.30 ± 0.42 | 1.63 | 1.60 ± 0.24 | 1.66 | 1.51 ± 0.14 |
Superoxide dismutase 1 (SOD1) | 21 | 5.62E-05 | 2.12 | 1.72 ± 0.24 | 1.57 | 1.44 ± 0.12 | 1.55 | 2.75 ± 1.37 | 1.74 | 2.86 ± 1.52 |
Cystatin B (stefin B) (CSTB) | 21 | 7.75E-05 | 1.69 | 1.21 ± 0.13 | 1.49 | 1.21 ± 0.14 | 1.18 | 1.92 ± 0.56 | 1.30 | 1.88 ± 0.07 |
Phosphofructokinase, liver (PFKL) | 21 | 1.93E-04 | 1.16 | 2.17 ± 0.14 | 1.92 | 1.35 ± 0.08 | 1.61 | 2.07 ± 0.44 | 1.11 | 2.23 ± 0.55 |
Pyridoxal (pyridoxine, vitamin B6) kinase (PDXK) | 21 | 2.82E-04 | 2.73 | 2.99 ± 0.40 | 2.13 | 1.79 ± 0.20 | 2.21 | 2.18 ± 1.01 | 1.44 | 1.75 ± 0.09 |
Collagen, type VI, alpha 1 (COL6A1) | 21 | 5.04E-04 | 1.72 | 3.16 ± 0.24 | 1.39 | 0.75 ± 0.06 | 1.45 | 2.57 ± 1.28 | 1.39 | 1.97 ± 0.76 |
Ubiquitin specific protease 16 (USP16) | 21 | 5.33E-04 | 1.80 | 2.75 ± 0.48 | 1.30 | 1.33 ± 0.36 | 1.67 | 1.70 ± 0.50 | 1.67 | 3.40 ± 1.54 |
SMT3 suppressor of mif two 3 homolog 1 (yeast) (SMT3H1) | 21 | 6.27E-04 | 1.68 | 1.66 ± 0.42 | 1.50 | 0.93 ± 0.08 | 1.56 | 2.56 ± 1.26 | 1.40 | 4.07 ± 2.71 |
Mitochondrial ribosomal protein L39 (MRPL39) | 21 | 7.48E-04 | 1.44 | 1.25 ± 0.08 | 1.04 | 1.40 ± 0.27 | 1.24 | 2.41 ± 1.14 | 1.41 | 1.91 ± 0.29 |
Interferon gamma receptor 2 (IFNGR2) | 21 | 8.16E-04 | 1.36 | 2.21 ± 0.29 | 1.36 | 1.78 ± 0.12 | 1.48 | 1.82 ± 0.44 | 1.27 | 1.27 ± 0.41 |
Human homolog of ES1 (zebrafish) protein (C21orf33) | 21 | 1.02E-03 | 1.48 | 5.44 ± 2.14 | 1.71 | 1.85 ± 0.40 | 1.06 | 1.21 ± 0.24 | 1.99 | 1.38 ± 0.16 |
Chaperonin containing TCP1, subunit 8 (theta) (CCT8) | 21 | 1.45E-03 | 1.38 | 2.51 ± 0.44 | 1.29 | 3.64 ± 0.92 | 1.94 | 1.09 ± 0.07 | 1.77 | 0.75 ± 0.04 |
Tryptophan rich basic protein (WRB) | 21 | 2.18E-03 | 1.89 | 5.21 ± 2.08 | 1.28 | 1.94 ± 0.39 | 1.83 | 2.87 ± 2.23 | 1.94 | 1.78 ± 0.44 |
HMT1 hnRNP methyl-transferase-like 1 (HRMT1L1) | 21 | 3.62E-03 | 1.37 | 1.50 ± 0.54 | 1.44 | 1.93 ± 0.36 | 0.96 | 1.46 ± 0.50 | 1.45 | 1.65 ± 0.05 |